Trials / Recruiting
RecruitingNCT06159764
National Registry of Cardioneuroablation in Recurrent Reflex Syncope
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- University Hospital, Bordeaux · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
This registry aims to collect patient data on cardioneuroablation for vasovagal syncope from multiple centers in France. The aim is to evaluate success rates, compare techniques and help institutions set up their own cardioneuroablation program
Detailed description
Cardioneuroablation is an emerging technique used to treat patients with vagally-mediated extrinsic bradycardia. It seems particularly efficient in patients with recurrent vasovagal syncope due to a strong cardioinhibitory effect. The procedure consists in using radiofrequency ablation to destroy cardiac ganglionated plexi located in epicardial fat pads around the atrias. Key questions concerning this procedure still remain unanswered: 1) What is the success rate of the procedure 2) Which patients will benefit from this technique? 3) Which fat pads should be targeted during the procedure? 4) What is the best way of identifying the location of these fat pads? 5) What are the long-term effects of this procedure? A multicenter registry seems ideal to try to answer these questions at minimal cost
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Cardioneuroablation | radiofrequency ablation to destroy cardiac ganglionated plexi located in epicardial fat pads around the atrias |
Timeline
- Start date
- 2024-11-27
- Primary completion
- 2026-01-31
- Completion
- 2026-01-31
- First posted
- 2023-12-07
- Last updated
- 2025-06-17
Locations
14 sites across 1 country: France
Source: ClinicalTrials.gov record NCT06159764. Inclusion in this directory is not an endorsement.